<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38294616</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1568-5608</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Inflammopharmacology</Title><ISOAbbreviation>Inflammopharmacology</ISOAbbreviation></Journal><ArticleTitle>Repurposing metformin to manage idiopathic or long COVID Tinnitus: self-report adopting a pathophysiological and pharmacological approach.</ArticleTitle><Pagination><StartPage>945</StartPage><EndPage>948</EndPage><MedlinePgn>945-948</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10787-023-01421-8</ELocationID><Abstract><AbstractText>Chronic tinnitus is a common neurological disorder that affects millions of patients globally with no available successful pharmacotherapy. It can be extremely bothersome to some patients to the extent that it occasionally qualifies as a disability that can hinder them from leading a normal life. In this short communication, the author discusses how he suffered from idiopathic tinnitus and how he managed to adopt a combined pathophysiological and pharmacological approach to the reason for the first time in the medical literature that low-dose metformin might be safely and effectively repurposed to manage at least a subset of tinnitus patients while discussing the potential role of adenosine receptor agonists as potential future tinnitus therapeutics.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kelleni</LastName><ForeName>Mina T</ForeName><Initials>MT</Initials><Identifier Source="ORCID">0000-0001-6290-6025</Identifier><AffiliationInfo><Affiliation>Pharmacology Department, College of Medicine, Minia University, Minya, 61111, Egypt. drthabetpharm@yahoo.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Inflammopharmacology</MedlineTA><NlmUniqueID>9112626</NlmUniqueID><ISSNLinking>0925-4692</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014012" MajorTopicYN="Y">Tinnitus</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adenosine</Keyword><Keyword MajorTopicYN="N">Adenosine receptors</Keyword><Keyword MajorTopicYN="N">Caffeine</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Metformin</Keyword><Keyword MajorTopicYN="N">Tinnitus</Keyword></KeywordList><CoiStatement>The authors have not disclosed any competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>31</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>31</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38294616</ArticleId><ArticleId IdType="pmc">PMC11006725</ArticleId><ArticleId IdType="doi">10.1007/s10787-023-01421-8</ArticleId><ArticleId IdType="pii">10.1007/s10787-023-01421-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aljuaid SM, Mirza AA, Habib LA, AlHarthi LA, Alansari BM, AlQahtani BG, Althobaiti YA. Does caffeine intake increase the incidence of Tinnitus? A systematic review. Int Arch Otorhinolaryngol. 2020;25:e628&#x2013;e632.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8558950</ArticleId><ArticleId IdType="pubmed">34737834</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt IS, Wilson N, Dias R, Torkamani A. A genome-wide association study of tinnitus reveals shared genetic links to neuropsychiatric disorders. Sci Rep. 2022;12:22511. doi: 10.1038/s41598-022-26413-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-26413-6</ArticleId><ArticleId IdType="pmc">PMC9800371</ArticleId><ArticleId IdType="pubmed">36581688</ArticleId></ArticleIdList></Reference><Reference><Citation>Colizza A, Ralli M, Turchetta R, Minni A, Greco A, De Vincentis M. Otolaryngology adverse events following COVID-19 vaccines. Eur Rev Med Pharmacol Sci. 2022;26:4113&#x2013;4116.</Citation><ArticleIdList><ArticleId IdType="pubmed">35731083</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardennes R, Al Anbar N, Rouillon F. Propofol-interrupted Tinnitus later suppressed by Amantadine: a case-report. J Clin Pharmacol. 2013;53:356&#x2013;358. doi: 10.1002/jcph.6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcph.6</ArticleId><ArticleId IdType="pubmed">23426878</ArticleId></ArticleIdList></Reference><Reference><Citation>Dattilo S, Mancuso C, Koverech G, Di Mauro P, Ontario ML, Petralia CC, Petralia A, Maiolino L, Serra A, Calabrese EJ, Calabrese V. Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases. Immun Ageing. 2015;12:20. doi: 10.1186/s12979-015-0046-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-015-0046-8</ArticleId><ArticleId IdType="pmc">PMC4634585</ArticleId><ArticleId IdType="pubmed">26543490</ArticleId></ArticleIdList></Reference><Reference><Citation>Degen CV, Mikuteit M, Niewolik J, Schr&#xf6;der D, Vahldiek K, M&#xfc;cke U, Heinemann S, M&#xfc;ller F, Behrens GMN, Klawonn F, Dopfer-Jablonka A, Steffens S. Self-reported Tinnitus and Vertigo or dizziness in a cohort of adult long COVID patients. Front Neurol. 2022;13:884002. doi: 10.3389/fneur.2022.884002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.884002</ArticleId><ArticleId IdType="pmc">PMC9082801</ArticleId><ArticleId IdType="pubmed">35547372</ArticleId></ArticleIdList></Reference><Reference><Citation>Demar&#xe9; S, Kothari A, Calcutt NA, Fernyhough P. Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system. Expert Rev Neurother. 2021;21:45&#x2013;63. doi: 10.1080/14737175.2021.1847645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2021.1847645</ArticleId><ArticleId IdType="pmc">PMC9482886</ArticleId><ArticleId IdType="pubmed">33161784</ArticleId></ArticleIdList></Reference><Reference><Citation>Elgandy MS and Coelho C (2022) Chapter 11. Tinnitus in children., In Tinnitus treatment : clinical protocols, Tyler RS and Perreau A (eds), Thieme Medical Publishers, Incorporated, NEW YORK, GERMANY</Citation></Reference><Reference><Citation>Figueiredo RR, Azevedo AAd and Penido NdO (2021) Chapter 16-Tinnitus features according to caffeine consumption, in Progress in Brain Research (Langguth B, Kleinjung T, De Ridder D, Schlee W and Vanneste S (Eds) Elsevier, pp 335&#x2013;344</Citation><ArticleIdList><ArticleId IdType="pubmed">33931187</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueiredo RR, Penido NdO, Azevedo AAd, Oliveira PMd, Siqueira AGd, Figueiredo GdMR, Schlee W, Langguth B. Tinnitus emerging in the context of a COVID-19 infection seems not to differ in its characteristics from tinnitus unrelated to COVID-19. Front Neurol. 2022;13:674179. doi: 10.3389/fneur.2022.974179.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.974179</ArticleId><ArticleId IdType="pmc">PMC9505692</ArticleId><ArticleId IdType="pubmed">36158941</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuxe K, Marcellino D, Borroto-Escuela DO, Guescini M, Fern&#xe1;ndez-Due&#xf1;as V, Tanganelli S, Rivera A, Ciruela F, Agnati LF. Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci Ther. 2010;16:e18&#x2013;e42. doi: 10.1111/j.1755-5949.2009.00126.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1755-5949.2009.00126.x</ArticleId><ArticleId IdType="pmc">PMC6493824</ArticleId><ArticleId IdType="pubmed">20345970</ArticleId></ArticleIdList></Reference><Reference><Citation>Gander PE and Tyler RS (2022) Chapter 1. Neurophysiological models, psychological models, and treatments for Tinnitus., in Tinnitus treatment : clinical protocols (Tyler RS and Perreau A (Eds), Thieme Medical Publishers, Incorporated, NEW YORK, GERMANY</Citation></Reference><Reference><Citation>Gomaa AA, Abdel-Wadood YA, Gomaa MA. Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild&#x2013;moderate COVID-19 and prevention of post-COVID cognitive impairment. Inflammopharmacology. 2022;30:1977&#x2013;1992. doi: 10.1007/s10787-022-01062-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-022-01062-3</ArticleId><ArticleId IdType="pmc">PMC9493173</ArticleId><ArticleId IdType="pubmed">36136251</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson KA, Tosh DK, Jain S, Gao ZG. Historical and current adenosine receptor agonists in preclinical and clinical development. Front Cell Neurosci. 2019;13:124. doi: 10.3389/fncel.2019.00124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00124</ArticleId><ArticleId IdType="pmc">PMC6447611</ArticleId><ArticleId IdType="pubmed">30983976</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelleni MT. Nitazoxanide/azithromycin combination for COVID-19: a suggested new protocol for early management. Pharmacol Res. 2020;157:104874. doi: 10.1016/j.phrs.2020.104874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.104874</ArticleId><ArticleId IdType="pmc">PMC7192107</ArticleId><ArticleId IdType="pubmed">32360581</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelleni MT. NSAIDs and Kelleni's protocol as potential early COVID-19 treatment game changer: could it be the final countdown? Inflammopharmacology. 2022;30:343&#x2013;348. doi: 10.1007/s10787-021-00896-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-021-00896-7</ArticleId><ArticleId IdType="pmc">PMC8613510</ArticleId><ArticleId IdType="pubmed">34822026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelleni MT. The African Kelleni's roadmap using nitazoxanide and broad-spectrum antimicrobials to abort returning to COVID-19 square one. Inflammopharmacology. 2023;31:3335&#x2013;3338. doi: 10.1007/s10787-023-01263-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-023-01263-4</ArticleId><ArticleId IdType="pmc">PMC10691980</ArticleId><ArticleId IdType="pubmed">37326756</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelleni MT. Real-life practice of the Egyptian Kelleni's protocol in the current tripledemic: COVID-19, RSV and influenza. J Infect. 2023;86:154&#x2013;225. doi: 10.1016/j.jinf.2022.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.12.007</ArticleId><ArticleId IdType="pmc">PMC9737510</ArticleId><ArticleId IdType="pubmed">36513168</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelleni MT. Real-world practice of the Egyptian Kelleni's protocol amid changing tropism of SARS-CoV-2 omicron BA.5.2.1.7, XBB 1.5 and CH.1.1 subvariants: a multi-purpose protocol. Inflammopharmacology. 2023;31:1559&#x2013;1560. doi: 10.1007/s10787-023-01180-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-023-01180-6</ArticleId><ArticleId IdType="pmc">PMC10018580</ArticleId><ArticleId IdType="pubmed">36928633</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly Radziwon, Sarah H. Hayes, Adam M. Sheppard, Dalian Ding and Salvi R (2015) Chapter 6. Drug induced Tinnitus, in Tinnitus: clinical and research perspectives (Fagelson M Ed), Plural, Publishing, Incorporated</Citation></Reference><Reference><Citation>Kim SH, Kim D, Lee J-M, Lee SK, Kang HJ, Yeo SG. Review of pharmacotherapy for Tinnitus. Healthcare. 2021 doi: 10.3390/healthcare9060779.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare9060779</ArticleId><ArticleId IdType="pmc">PMC8235102</ArticleId><ArticleId IdType="pubmed">34205776</ArticleId></ArticleIdList></Reference><Reference><Citation>Lentferink YE, Knibbe CAJ, van der Vorst MMJ. Efficacy of metformin treatment with respect to weight reduction in children and adults with obesity: a systematic review. Drugs. 2018;78:1887&#x2013;1901. doi: 10.1007/s40265-018-1025-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-018-1025-0</ArticleId><ArticleId IdType="pubmed">30511324</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Zhou T, Fei E. Actions of metformin in the brain: a new perspective of metformin treatments in related neurological disorders. Int J Mol Sci. 2022 doi: 10.3390/ijms23158281.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23158281</ArticleId><ArticleId IdType="pmc">PMC9368983</ArticleId><ArticleId IdType="pubmed">35955427</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez MA, Esteban-Ortega F. Tinnitus dopaminergic pathway. Ear noises treatment by dopamine modulation. Med Hypotheses. 2005;65:349&#x2013;352. doi: 10.1016/j.mehy.2005.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2005.02.016</ArticleId><ArticleId IdType="pubmed">15922111</ArticleId></ArticleIdList></Reference><Reference><Citation>Paiva M, Riksen NP, Davidson SM, Hausenloy DJ, Monteiro P, Gon&#xe7;alves L, Provid&#xea;ncia L, Rongen GA, Smits P, Mocanu MM, Yellon DM. Metformin prevents myocardial reperfusion injury by activating the adenosine receptor. J Cardiovasc Pharmacol. 2009;53:373. doi: 10.1097/FJC.0b013e31819fd4e7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0b013e31819fd4e7</ArticleId><ArticleId IdType="pubmed">19295441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross AE, Venton BJ. Adenosine transiently modulates stimulated dopamine release in the caudate&#x2013;putamen via A1 receptors. J Neurochem. 2015;132:51&#x2013;60. doi: 10.1111/jnc.12946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12946</ArticleId><ArticleId IdType="pmc">PMC4270927</ArticleId><ArticleId IdType="pubmed">25219576</ArticleId></ArticleIdList></Reference><Reference><Citation>Schloss JV. Nutritional deficiencies that may predispose to long COVID. Inflammopharmacology. 2023;31:573&#x2013;583. doi: 10.1007/s10787-023-01183-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-023-01183-3</ArticleId><ArticleId IdType="pmc">PMC10015545</ArticleId><ArticleId IdType="pubmed">36920723</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan M (2012) Chapter 19. Tinnitus, in The patient history: an evidence-based approach to differential diagnosis, 2e (Henderson MC, Tierney LM and Smetana GW eds), The McGraw-Hill Companies, New York, NY</Citation></Reference><Reference><Citation>Trinidade A, Robinson T, Phillips JS. The role of caffeine in otorhinolaryngology: guilty as charged? Eur Arch Otorhinolaryngol. 2014;271:2097&#x2013;2102. doi: 10.1007/s00405-013-2648-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-013-2648-0</ArticleId><ArticleId IdType="pubmed">23934351</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YW, He SJ, Feng X, Cheng J, Luo YT, Tian L, Huang Q. Metformin: a review of its potential indications. Drug Des Devel Ther. 2017;11:2421&#x2013;2429. doi: 10.2147/DDDT.S141675.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S141675</ArticleId><ArticleId IdType="pmc">PMC5574599</ArticleId><ArticleId IdType="pubmed">28860713</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Investig. 2001;108:1167&#x2013;1174. doi: 10.1172/JCI13505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI13505</ArticleId><ArticleId IdType="pmc">PMC209533</ArticleId><ArticleId IdType="pubmed">11602624</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>